Diabetes might not have touched you personally but if you think then you will definitely know either someone who has it or had it and is no longer with us. Some forms of Diabetes are very aggressive and the cure is not as a effective as one wants it to be, thus the people who are effected by it are suffering from it. I understand that it is easy to look the other way sometimes especially if this disease has not had much difference in your life or the lives of your close ones but one should always be aware that there are many people who are suffering from it and are very much effected by it and they have no choice but to fight for their lives.
Be aware and spread the word out, help if you can those who are trying to find the cure, volunteer or at least know where to refer someone if anyone asks where they can get help. Know Diabetes Research Institute and their website: www.drif.org
Silent Auction was Held to raise necessary funds to further the research to FIND the CURE: Pictures
This year the Honorees and Recipients of the Dare to Dream Award of the evening were Bob DeRoose and Michel Nischan with Alan Kalter being the Master of Ceremonies.
Bob DeRoose - President and CEO, Kobrand Corporation http://www.kobrandwineandspirits.com/
Bob DeRoose assumed the Presidency and C.E.O. position on January 1st, 2010 after a storied track record of over 27 years with Kobrand. Bob was hired in 1983 fresh out of graduate school to assume street sales responsibilities in Chicago (his home town). Bob is a graduate of DePaul University where he double-majored in Finance and Marketing and stayed on to work his way through the DePaul MBA
program. Having secured street sales experience and an understanding of Kobrand’s sales systems, Bob moved to Phoenix in 1985 to assume sales management responsibilities for Arizona and Nevada. In 1987, Bob was promoted to the position of Pacific Division Manager, managing eight Northwest states and Northern California (based out of San Francisco). In 1990, Bob returned “home” to Chicago to oversee the Central Group, the second largest sales territory at Kobrand. In 1996, Bob was promoted to Assistant to the President, a role in which he was tasked with designing and driving the construction of the Kobrand sales and technology systems as well as overseeing all administration functions.
In 2003, Bob assumed the additional responsibilities of National Sales Manager and in 2006 those responsibilities were expanded to include
export / global sales, at which time he became Kobrand’s Chief Operating Officer, Director of Corporate Sales.
Bob lives in Weston, CT with his wife Susan and when not working can be found salt water fishing on the flats of Key West, FL.
Michel Nischan- http://michelnischan.com/
|
Q&A with World Renowned Chef Michel Nischan
http://www.jdrf.org/index.cfm?page_id=104065
Michel Nischan, renowned chef, best-selling author, and winner of the 2004 James Beard Foundation Cookbook Award, is credited with creating a cuisine of well-being. He focuses on pure ingredients and allows their natural flavors to dominate his dishes. Chef Nischan offered to share his personal relationship to type 1 diabetes (juvenile diabetes) and provides nutrition and cooking tips for people with type 1 diabetes.JDRF: How did you react to learning that your son had type 1 diabetes?
Michel Nischan: It was different with each son. Chris, who is now 15, was diagnosed at age 5. Both Lori and I were stunned, saddened, and angry. First we thought, "Why Chris? Why should this beautiful young boy have to go through something like this?" Then we realized we had to mobilize as a family. We decided that whatever changes in diet had to be made, the whole family would make together. When Ethan was diagnosed two years ago at age 2, we thought, "Enough already!" Interestingly, our shock was very short lived and quickly replaced with the realization that it was better us than someone else because we were equipped to deal with it. We also view it as a reaffirmation of my quest toward cooking for well-being. To read the rest of the interview click on the link below Q &A.
Michel Nischan & His family and friends at the Gala
Michel Nischan & Gary Kleiman by Anna Kuchma
D.R.E.a.M.S. 2010 Chairs : Bonnie Inserra & Samantha Shanken Baker By Anna Kuchma
Bonnie Inserra &; Lindsey Inserra (Mother - Chair, Daughter - Young Professional Chairs)
Inserra Relatives
Jean Shafiroff & Dawne Marie Grannum by Anna Kuchma
EMCEE - ALAN KALTER -
Camillo Ricordi, M.D.
After medical school (University of Milan, Italy) Camillo Ricordi, M.D., received an NIH Research Trainee Award at Washington University in St. Louis (1986-1988), and spent four years (1989-1993) as Director of Cellular Transplantation at the University of Pittsburgh Transplantation Institute.
Since 1993, he has been at the University of Miami, where he holds the Stacy Joy Goodman Chair. He serves as Distinguished Professor of Medicine and Professor of Surgery, Biomedical Engineering, Microbiology and Immunology. Dr. Ricordi is also Chief of the Division of Cellular Transplantation, Department of Surgery and the Scientific Director and Chief Academic Officer of the Diabetes Research Institute at the University of Miami Miller School of Medicine.
Acknowledged by his peers as one of the world's leading scientists in cell transplantation, Dr. Ricordi is well-known for developing the Automated Method for Islet Isolation (the "Ricordi Chamber"). The procedure made it possible to isolate large numbers of pancreatic islets and is now used by laboratories performing clinical islet transplants worldwide.
Dr. Ricordi led the team that performed the first series of successful clinical islet allografts in 1990 and performed the first clinical trials of islet-donor bone marrow cell infusions and more recently islet-donor CD34+ cell infusions with the objective to treat patients with Type 1 diabetes without the continuous requirement for anti-rejection drugs. His research objective is to develop a cure for Type 1 Diabetes.
Dr. Ricordi was founder and president of the Cell Transplant Society (1992-94), co-founder of the National Diabetes Research Coalition (Chairman 1997) and president of the International Association for Pancreas and Islet Transplantation (1999-2001; IPITA).
Currently a member of the council of the International Transplantation Society, he also served on the council of the American Society of Transplant Surgeons (2000-2002), on the National Institutes of Health (NIH-NIAID) Expert Panel on clinical approaches for tolerance induction, and on the FDA Biologic Response Modifiers Advisory Committee. Dr. Ricordi is also serving on the NIH/NCRR Islet Cell Resources (ICRs) Executive Committee, as Chairperson of the Clinical Islet Transplant Consortium (NIDDK-NIAID) and as President of the Board of the Mediterranean Institute for Transplantation and Advanced Therapies (ISMETT, Palermo, Italy).
Dr. Ricordi has received numerous honors and awards, including the 2001 Nessim Habif World Prize of Surgery (University of Geneva) for developing a machine and a technology that significantly contributed to the advancement of a surgical field. He was also awarded the 2002 Outstanding Scientific Achievement Award and delivered the Lilly Lecture at the 2002 Congress of the American Diabetes Association.
He has been serving on the editorial boards of several scientific journals, including Cell Transplantation (Editor-in-Chief), American Journal of Transplantation (Associate Editor), Transplantation, Transplantation Proceedings, and Tissue Engineering. Dr. Ricordi has authored more than 500 scientific publications. As inventor, he was awarded nine patents.
Website: http://www.diabetesresearch.org/Page.aspx?pid=229
Since 1993, he has been at the University of Miami, where he holds the Stacy Joy Goodman Chair. He serves as Distinguished Professor of Medicine and Professor of Surgery, Biomedical Engineering, Microbiology and Immunology. Dr. Ricordi is also Chief of the Division of Cellular Transplantation, Department of Surgery and the Scientific Director and Chief Academic Officer of the Diabetes Research Institute at the University of Miami Miller School of Medicine.
Acknowledged by his peers as one of the world's leading scientists in cell transplantation, Dr. Ricordi is well-known for developing the Automated Method for Islet Isolation (the "Ricordi Chamber"). The procedure made it possible to isolate large numbers of pancreatic islets and is now used by laboratories performing clinical islet transplants worldwide.
Dr. Ricordi led the team that performed the first series of successful clinical islet allografts in 1990 and performed the first clinical trials of islet-donor bone marrow cell infusions and more recently islet-donor CD34+ cell infusions with the objective to treat patients with Type 1 diabetes without the continuous requirement for anti-rejection drugs. His research objective is to develop a cure for Type 1 Diabetes.
Dr. Ricordi was founder and president of the Cell Transplant Society (1992-94), co-founder of the National Diabetes Research Coalition (Chairman 1997) and president of the International Association for Pancreas and Islet Transplantation (1999-2001; IPITA).
Currently a member of the council of the International Transplantation Society, he also served on the council of the American Society of Transplant Surgeons (2000-2002), on the National Institutes of Health (NIH-NIAID) Expert Panel on clinical approaches for tolerance induction, and on the FDA Biologic Response Modifiers Advisory Committee. Dr. Ricordi is also serving on the NIH/NCRR Islet Cell Resources (ICRs) Executive Committee, as Chairperson of the Clinical Islet Transplant Consortium (NIDDK-NIAID) and as President of the Board of the Mediterranean Institute for Transplantation and Advanced Therapies (ISMETT, Palermo, Italy).
Dr. Ricordi has received numerous honors and awards, including the 2001 Nessim Habif World Prize of Surgery (University of Geneva) for developing a machine and a technology that significantly contributed to the advancement of a surgical field. He was also awarded the 2002 Outstanding Scientific Achievement Award and delivered the Lilly Lecture at the 2002 Congress of the American Diabetes Association.
He has been serving on the editorial boards of several scientific journals, including Cell Transplantation (Editor-in-Chief), American Journal of Transplantation (Associate Editor), Transplantation, Transplantation Proceedings, and Tissue Engineering. Dr. Ricordi has authored more than 500 scientific publications. As inventor, he was awarded nine patents.
Website: http://www.diabetesresearch.org/Page.aspx?pid=229
Camillo Ricordi, M.D., born on April 1, 1957, concluded his graduate/post-graduate studies and his surgical residency with the highest scores and honors. Dr. Ricordi is the Stacy Joy Goodman Professor of Surgery and Medicine and Chief of the Division of Cellular Transplantation, at the University of Miami School of Medicine. In September 1996, he assumed the position of Scientific Director and Chief Academic Officer of the Diabetes Research Institute.
Prior to joining the DRI, Dr. Ricordi served as Attending Surgeon at the San Raffaele Institute, University of Milan School of Medicine (1988-1989). He then spent four years as Associate Professor of Surgery and Director of Cellular Transplantation at the University of Pittsburgh Transplantation Institute (1989-1993).
Dr. Ricordi is well-known for inventing the machine that made it possible to isolate large numbers of islet cells from the human pancreas. The procedure is now used by laboratories performing clinical islet transplants. Acknowledged by his peers as one of the world's leading scientists in islet transplantation, Dr. Ricordi has trained the majority of islet cell transplant researchers worldwide and has developed highly innovative strategies in an attempt to transplant islets without the continuous requirement for immunosuppressive drugs.
Dr. Ricordi is founder and past president of the Cell Transplant Society, co-founder and steering committee member of the International Association for Pancreas and Islet Transplantation (IPITA), and co-founder of the National Diabetes Research Coalition. Dr. Ricordi is also an active member of The Transplantation Society, the American Diabetes Association, the American Federation of Clinical Research, and the American Society of Transplant Surgeons. Additionally, Dr. Ricordi has been a reviewer of application grants for a number of organizations, including the European Economic Community, National Institutes of Health, Canadian Diabetes Association, and the Juvenile Diabetes Foundation.
Website:http://www.childrenwithdiabetes.com/dteam/d_0d_00h.htm
OTHER GUESTS:
Singer Shontelle - Website :http://www.shontellemusic.com/
By Anna Kuchma
More Pictures and Interviews are Coming Up.
No comments:
Post a Comment